findmyKOL

Curt Littler, MD

Basic profile

Sharp Rees-Stealy Medical Group

ORCIDNone on fileNPI
RegionSan Diego, CA · WestSpecialtyDermatologyFocusDermatology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Curt Littler is a Dermatology physician affiliated with Sharp Rees-Stealy Medical Group. OpenAlex indexes 14 publications with 670 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
14publications

Distinct works indexed by OpenAlex.

670citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    31.7%
    Corticosteroid23.4%
    Clobetasol Propionate76%Hydrocortisone24%
    Part D<11 patients
    Aminoglycoside Antibacterial8.3%
    Gentamicin Sulfate100%
    Part D18 patients
  • Cancer & immunology

    13.9%
    Folate Analog Metabolic Inhibitor9.1%
    Methotrexate100%
    Part D<11 patients
    Nucleoside Metabolic Inhibitor4.8%
    Fluorouracil100%
    Part D<11 patients
  • Dermatology

    13.5%
    Corticosteroid8.3%
    Triamcinolone Acetonide100%
    Part D<11 patients
    Other antifungals for topical use5.2%
    Ciclopirox100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”